Core Insights - CBL & Associates Properties (CBL) has experienced significant volatility in its share price in 2025, typical for a retail REIT with high leverage [1] - Despite the volatility, CBL has achieved a total return of approximately 15% year-to-date, which is notably above market expectations [1] Company Overview - CBL is a retail Real Estate Investment Trust (REIT) that employs significant leverage, impacting its share price stability [1] - The company has a focus on long-term fundamental investment strategies, particularly in REITs, preferred stocks, and high-yield bonds [1] Investment Strategy - The investment approach includes combining long stock positions with covered calls and cash secured puts, indicating a strategy aimed at risk management and income generation [1] - The analysis primarily covers REITs and financials, with occasional insights into ETFs and macro-driven stock ideas [1]

Financial Performance - Net income for the three months ended September 30, 2025, was $75.060 million, compared to $15.753 million for the same period in 2024, representing a significant increase [158]. - Net income attributable to common shareholders for the nine months ended September 30, 2025, was $85.631 million, up from $20.140 million in 2024, indicating strong growth [158]. - Total revenues for the three months ended September 30, 2025, were $139.280 million, an increase of $14.191 million compared to $125.089 million in 2024 [166]. - Total revenues for the nine months ended September 30, 2025, increased by $38.1 million to $421.9 million, driven by rental revenue growth from the consolidation of three malls and acquisition of four malls [174]. - A total gain of $74.1 million was recognized on sales of real estate assets during the nine months ended September 30, 2025, compared to a $16.5 million gain in the prior-year period [183]. Revenue and Rental Growth - Rental revenues increased by $14.8 million for the three months ended September 30, 2025, primarily due to the consolidation of three malls and the acquisition of four malls [166]. - Rental revenues increased by $68.0 million during the current-year period, offset by $25.5 million from properties sold since the prior-year period [174]. - Rental revenues for the three months ended September 30, 2025, were $0.3 million higher, primarily due to increased minimum rents and percentage rents [189]. - The majority of revenues for the nine months ended September 30, 2025, were derived from malls (71.4%), followed by open-air centers (10.5%) and lifestyle centers (7.8%) [193]. Operating Expenses - Total operating expenses increased by $16.188 million for the three months ended September 30, 2025, primarily due to the consolidation and acquisition of malls [167]. - Total operating expenses increased by $44.1 million for the nine months ended September 30, 2025, primarily due to the consolidation of three malls and acquisition of four malls [175]. - General and administrative expenses rose by $2.4 million primarily due to fees related to the modification of a non-recourse bank loan [169]. - Depreciation and amortization expense increased by $7.574 million for the three months ended September 30, 2025, due to the addition of tangible and intangible assets from recent acquisitions [168]. - Depreciation and amortization expense rose by $45.7 million, mainly due to the addition of tangible and intangible assets from the consolidation and acquisition of malls [176]. Impairment and Losses - The company reported a loss on impairment of $1.736 million related to a land parcel sold below its carrying value during the three months ended September 30, 2025 [169]. - A loss on impairment of $3.2 million was recorded related to the sales of 840 Greenbrier Circle and a land parcel, sold for less than their carrying values [178]. Debt and Financing - As of September 30, 2025, the total outstanding debt was $2,679.4 million, with $2,676.6 million classified as non-recourse debt obligations [212]. - The weighted-average interest rate for total fixed-rate and variable-rate debt was 5.99% [216]. - A 0.5% increase in interest rates on variable-rate debt would increase annual interest expense by approximately $3.8 million [245]. - A 0.5% increase in interest rates would decrease the fair value of total debt by approximately $22.9 million, while a 0.5% decrease would increase the fair value by approximately $23.8 million [246]. - The company modified loans secured by various properties, increasing the principal balance on the 2032 non-recourse bank loan by $110.0 million to fund acquisitions [205]. Cash Flow and Dividends - Cash provided by operating activities increased to $169.5 million for the nine months ended September 30, 2025, up from $156.0 million in the prior year [208]. - Cash used in investing activities was $(73.8) million for the nine months ended September 30, 2025, primarily due to the acquisition of four malls [210]. - The company paid common stock dividends of $0.40 per share in Q1 and Q2 2025, and $0.45 per share in Q3 2025, along with a special dividend of $0.80 per share in Q1 2025 [206]. Occupancy and Leasing Activity - Portfolio occupancy as of September 30, 2025, was 90.2%, up from 89.3% in 2024, with total malls occupancy increasing to 87.6% from 86.4% [195]. - New leases signed in the three months ended September 30, 2025, totaled 203,948 square feet, compared to 143,207 square feet in the same period in 2024 [196]. - Total new and renewal leasing activity for 2025/2026 amounted to 807 leases covering 2,543,377 square feet, with an average initial rent of $38.70 PSF [200]. - The average rent spread for new leases commencing in 2025 was 31.8%, while renewal leases experienced a decline of 3.5% [200]. Joint Ventures and Affiliates - The company may enter into joint ventures to capitalize on land and development opportunities, earning development fees and management fees [227]. - The company guarantees joint venture debt to secure lower funding costs, resulting in higher returns for both the joint venture and the company [228]. - The company has ownership interests in 24 unconsolidated affiliates as of September 30, 2025 [226]. Accounting and Estimates - FFO is defined as net income excluding gains or losses on sales of depreciable properties, plus depreciation and amortization, providing a clearer picture of operating performance [232]. - The company evaluates its accounting estimates and assumptions regularly, which may impact the carrying values of assets and liabilities [230]. - There have been no material changes to the company's critical accounting policies during the nine months ended September 30, 2025 [231].

Financial Performance - CBL Properties reported a 1.1% increase in same-center NOI for Q3 2025, with total same-center NOI reaching $101.3 million compared to $100.1 million in Q3 2024[9]. - Funds from Operations (FFO), as adjusted, per share for Q3 2025 was $1.55, slightly up from $1.54 in Q3 2024, while year-to-date FFO, as adjusted, per share was $4.94 compared to $4.78 for the same period in 2024[9]. - Total revenues for Q3 2025 reached $139.280 million, a 11.5% increase from $125.089 million in Q3 2024[49]. - Rental revenues increased to $134.786 million in Q3 2025, up 12.3% from $119.992 million in Q3 2024[49]. - Net income attributable to common shareholders for Q3 2025 was $74.267 million, compared to $15.865 million in Q3 2024, representing a significant increase of 367.5%[49]. - FFO (Funds From Operations) allocable to Operating Partnership common unitholders for Q3 2025 was $67.819 million, up 72.1% from $39.435 million in Q3 2024[51]. - Diluted earnings per share for Q3 2025 were $2.38, a substantial increase from $0.52 in Q3 2024[57]. - Total expenses for Q3 2025 were $109.415 million, compared to $93.227 million in Q3 2024, reflecting a 17.4% increase[49]. - The company reported a gain on sales of real estate assets of $51.228 million in Q3 2025, compared to $12.816 million in Q3 2024[49]. - The company recognized a loss on impairment of $1.736 million in Q3 2025, compared to no impairment loss in Q3 2024[49]. Occupancy and Leasing - Portfolio occupancy increased by 90 basis points to 90.2% as of September 30, 2025, compared to 89.3% a year earlier[9]. - Tenant sales per square foot for the same-center increased approximately 4.8% in Q3 2025, with a 12-month trailing figure of $432 per square foot, reflecting a 1.6% increase year-over-year[9]. - CBL executed over 972,000 square feet of leases in Q3 2025, with new leases showing a 70.6% increase in average rents compared to prior rents[9]. - The occupancy rate for total acquired properties was 93.0% as of September 30, 2025[101]. - In-line occupancy for total malls improved to 89.4% in 2025 from 88.0% in 2024, indicating a year-over-year increase of 1.4 percentage points[99]. - The in-line occupancy rate for Lifestyle Centers remained stable at 91.9% in 2025, slightly up from 91.8% in 2024[99]. - The in-line occupancy for Outlet Centers increased to 94.9% in 2025 from 94.1% in 2024, marking an improvement of 0.8 percentage points[100]. Debt and Financing - A new $43.0 million non-recourse loan was secured at a 5.9% interest rate, representing a 160-basis point improvement over the previous rate[20]. - The existing loan of $333.0 million was modified to include the acquisition properties, increasing the principal balance to $443.0 million with a fixed interest rate of 7.70% for the initial term[28]. - The company's share of consolidated and unconsolidated debt as of September 30, 2025, totaled $2,583,740,000, with a weighted-average interest rate of 5.99%[64]. - The company's share of unconsolidated affiliates' debt was $389,129,000 as of September 30, 2025[64]. - Total consolidated debt as of September 30, 2025, was $2,273,721,000, compared to $1,512,637,000 in 2024[78]. - Weighted-average interest rate on total consolidated debt was 6.02% as of September 30, 2025, compared to 5.38% in 2024[78]. - The company has a weighted-average interest rate of 7.29% on its consolidated and unconsolidated debt[86]. Guidance and Projections - CBL reaffirmed its FFO guidance for 2025 in the range of $6.98 - $7.34 per share, anticipating same-center NOI to change between (2.0)% to 0.5%[30]. - The estimated 2025 same-center NOI is projected to be between $410.1 million and $420.6 million, reflecting a potential decline of (2.0)% to growth of 0.5%[31]. - Expected diluted earnings per common share for 2025 are estimated between $3.21 and $3.57, with adjusted FFO per diluted share projected at $6.98 to $7.34[32]. - CBL's total estimated capital items for 2025 range from $137.5 million to $167.5 million, including maintenance capital and development expenditures[35]. Capital Expenditures and Investments - Total capital expenditures for the three months ended September 30, 2025, were $16,331,000, compared to $17,303,000 in 2024, while total capital expenditures for the nine months ended September 30, 2025, were $41,112,000, up from $35,119,000 in 2024[129]. - CBL's share of the total cost for the Mayfaire Town Center hotel development is $15,435,000, with an expected yield of 11.0% upon opening in August 2025[132]. - The company reported a net investment in real estate assets of $1,885,470,000 as of September 30, 2025, compared to $1,871,492,000 as of December 31, 2024[67]. Market Strategy and Future Plans - CBL's acquisition strategy included adding four dominant malls to its portfolio in July, enhancing its cash flow opportunities[12]. - The company is focusing on expanding its Lifestyle and Open-Air Centers to attract more local and regional customers[92]. - Future strategies include potential acquisitions and repositioning of properties to enhance overall portfolio performance[94]. - The company is focusing on market expansion and redevelopment strategies to enhance overall portfolio performance[104].

Core Insights - Nurix Therapeutics, Inc. presented new translational data from its ongoing Phase 1 study of NX-1607, a first-in-class oral inhibitor of CBL-B, at the SITC 2025 Annual Meeting, highlighting its potential in treating advanced solid tumors [1][4] Group 1: Clinical Data and Findings - The new data from the Phase 1a clinical trial showed that NX-1607 resulted in dose-dependent pharmacologic activity, leading to increased peripheral T cell activation and proliferation, particularly in patients with stable disease [2][7] - A case study of a patient with metastatic castration-resistant prostate cancer (mCRPC) indicated that treatment with NX-1607 was associated with an expansion of activated peripheral memory T cell subsets and enhanced immune activation gene signatures [3][7] - The findings suggest that NX-1607 induces peripheral immune activation linked to remodeling of the tumor microenvironment, which may contribute to local tumor control [3][7] Group 2: Mechanism and Rationale - CBL-B inhibition is supported as a novel immune-oncology therapy, with NX-1607 showing signs of immune activation and disease control in heavily pretreated patients [4][6] - The treatment demonstrated dose-dependent pharmacokinetics and pharmacodynamic modulation, confirming target engagement and inhibition of CBL-B-mediated signaling [7] - Transcriptomic analyses revealed dose-dependent enrichment of immune signaling pathways, further supporting the mechanistic link between NX-1607 exposure and immune activation [7] Group 3: Company Overview - Nurix Therapeutics is focused on developing targeted protein degradation medicines for cancer and autoimmune diseases, with a pipeline that includes inhibitors of CBL-B and Bruton's tyrosine kinase [8] - The company is advancing multiple potentially first-in-class or best-in-class therapies, leveraging a fully AI-integrated discovery engine to enhance drug development [8]

Core Insights - CBL Properties has opened a new Primark store at CoolSprings Galleria in Nashville, Tennessee, marking the second Primark location in the state and the first in CBL's portfolio [1][2] Company Overview - CBL Properties is headquartered in Chattanooga, TN, and manages a national portfolio of 88 properties totaling 53.9 million square feet across 22 states, including 55 enclosed malls and various retail centers [4] Retail Expansion - The new Primark store spans 35,000 square feet and offers a variety of products including fashion, homeware, and beauty items [2] - CBL has recently added several new retailers to CoolSprings Galleria, including LEGO, LoveSac, and Miss A, with Vans expected to open this winter [3] Community Engagement - The opening weekend of Primark included live music, giveaways, and a special appearance from the character Bluey, indicating a strong community engagement strategy [2]

Core Viewpoint - CBL Properties has authorized a new stock repurchase program to buy up to $25 million of its common stock, replacing the previous program initiated on May 1, 2025 [1] Summary by Relevant Sections - **Stock Repurchase Program** - The new program allows CBL Properties to allocate additional capital for investment opportunities [1] - The previous program resulted in the acquisition of 248,590 shares for $7.3 million [1]

Group 1 - Alluvial Capital Management's fund rose 15.5% in Q3 2025, with year-to-date returns at 33.6%, marking the third-best quarterly result in its 9-year history [1] - CBL & Associates Properties, Inc. (NYSE:CBL) experienced a one-month return of -4.08% and a 52-week gain of 9.82%, closing at $29.42 per share with a market capitalization of $910.05 million on October 28, 2025 [2] - CBL & Associates Properties, Inc. is upgrading its mall portfolio by selling weaker class C properties and refinancing agreements to reduce interest costs, which strengthens its financial position and cash flow for distributions and investments [3] Group 2 - CBL & Associates Properties, Inc. is not among the 30 most popular stocks among hedge funds, with 24 hedge fund portfolios holding the stock at the end of Q2 2025, an increase from 23 in the previous quarter [4] - While CBL is acknowledged for its investment potential, certain AI stocks are considered to offer greater upside potential and less downside risk [4] - Alluvial Capital Management's views on CBL were also discussed in the previous quarter, indicating ongoing interest in the company's performance [5]

Core Viewpoint - CBL Properties has successfully sold its interest in Fremaux Town Center for $30.77 million, confirming the value of its open-air portfolio and reducing joint venture exposure [1][2]. Group 1: Transaction Details - The sale involved a 640,000-square-foot open-air center located in Slidell, LA, and resulted in the elimination of $35.0 million in property-specific debt [1]. - The transaction was completed at an 8.2% cap rate, indicating a favorable pricing environment for CBL's assets [1]. Group 2: Strategic Implications - The CEO of CBL Properties highlighted that the sale simplifies the ownership structure and allows the company to pursue higher-yield opportunities, including future acquisitions and share repurchase activities [2]. - The cash proceeds from the sale will be utilized to enhance the company's investment strategy and overall portfolio performance [2]. Group 3: Company Overview - CBL Properties is headquartered in Chattanooga, TN, and manages a national portfolio of 88 properties totaling 53.9 million square feet across 22 states, including various types of retail centers [3]. - The company focuses on active management, aggressive leasing, and profitable reinvestment to strengthen its portfolio [3].

Core Insights - NX-1607 is a first-in-class oral inhibitor of CBL-B, demonstrating on-target peripheral immune activation and anti-tumor activity in heavily pretreated patients with advanced solid tumors [1][2][4] - The clinical data presented at ESMO 2025 supports the initiation of expansion cohorts for further evaluation of NX-1607 as a monotherapy or in combination therapies [1][2] Company Overview - Nurix Therapeutics, Inc. is a clinical-stage biopharmaceutical company focused on targeted protein degradation medicines, aiming to improve treatment options for cancer and inflammatory diseases [7] - The company is advancing multiple clinical and preclinical programs, including NX-1607 and bexobrutideg, an oral BTK degrader [7] Clinical Data Summary - In a Phase 1a study, 82 patients with various solid tumors were treated with NX-1607 across different dosing regimens, showing dose-dependent exposure and clinical activity [2][3] - The disease control rate (DCR) was reported at 49.3%, with notable reductions in tumor-specific biomarkers such as PSA and CEA [2][3] - The treatment was well-tolerated, with most adverse events being Grade 2 or less, and immune-related adverse events indicating on-target immune activation [3][4] Therapeutic Potential - NX-1607 targets a previously unaddressed pathway in immune regulation, affecting multiple immune cell types, which may enhance its efficacy in treating solid tumors [2][6] - The results are particularly promising for tumor types like micro-satellite stable colorectal cancer and metastatic prostate cancer, where current immunotherapies have shown limited efficacy [4]

Group 1 - The investment approach has received over 500 five-star reviews, indicating high satisfaction among members who are experiencing benefits [1] - The company invests significant resources, over $100,000 annually, into researching profitable real estate investment opportunities [1] - The leader of the investing group High Yield Landlord shares a real-money REIT portfolio and transactions in real-time, providing features like buy/sell alerts and direct access to analysts [2] Group 2 - Jussi Askola, the President of Leonberg Capital, is recognized for his expertise in REIT investing, having authored award-winning academic papers and built relationships with top REIT executives [2] - The investment group offers three distinct portfolios: core, retirement, and international, catering to various investment strategies [2]